Main description:

A complete how-to guide for incorporating genomics into all applicable areas of clinical medicine

Precision Medicine: A Guide to Genomics in Clinical Practice is a comprehensive, yet succinct overview of the practice of genomic medicine. It is written for general healthcare practitioners, specialists, and trainees with the goal of providing detailed guidance on how to incorporate genomic medicine into daily practice. To be as clinically relevant as possible, the book intentionally avoids excessive technical content and consistently emphasizes real-life patient care and decision support.

Precision Medicine: A Guide to Genomics in Clinical Practice follows the course of a human life, beginning before conception through pregnancy, childhood, and adulthood, discussing the current and future applications of genomics and precision medicine at each stage. This organization allows healthcare providers to easily find the information relevant to their practice. Throughout, the authors highlight common pitfalls - technical and ethical - that might complicate the delivery of quality genomic healthcare. The book is enhanced by eleven valuable appendices that cover important topics ranging from the basics of genetics to ethical issues to regulation and reimbursement.

If you are searching for a clinically relevant, non-technical resource that will teach you how genomic medicine can and should be practiced in your specific field of interest, Precision Medicine: A Guide to Genomics in Clinical Practice belongs on your desk.

Contents:

Chapters 1-4: Pregnancy and childhood

Chapter 1: Preconception

What are the applications of precision medicine in the preconception period?

Infertility
Carrier screening - traditional and expanded
Genetic counselling, reimbursement, where to get tested
Future prospects: Preimplantation genetic testing

Chapter 2: Pregnancy

What are the applications of precision medicine during pregnancy?

Triple/quad screening
Amniocentesis/CVS
Trisomy testing using non-invasive (cfDNA) methods
Future prospects: expanded uses of cfDNA testing during pregnancy

Chapter 3: The Newborn

What are the applications of precision medicine in the newborn period? What are the situations when a clinician should consider a genetic diagnosis, what tests are commonly used, what evaluation can be performed by the non-specialist versus when to refer to a specialist.

Mandatory newborn screening
Broad classification and evaluation of birth defects
Broad classification and evaluation of metabolic disease
Future prospects: Sequencing from birth

Chapter 4: Childhood and Adolescence

What are the applications of precision medicine during childhood and adolescence?

Autism and Developmental delay
Childhood cancer (hereditary cancer)
Rare diseases and diagnostic sequencing
Support and advocacy for rare diseases

Chapters 5-9: Adulthood

Chapter 5: Pharmacogenetics

What pharmacogenetic tests are available? How valid and useful are they?

Types of pharmacogenetic markers

Efficacy-based, companion diagnostics
Safety-based, avoiding severe adverse events
Dosing-based

Understanding CYP450 alleles
Sources of information about pharmacogenetic tests

Drug labels
Evidence guidelines
PharmGKB, Dutch group

Chapter 6: Heart Disease

How is precision medicine being applied in heart disease?

Predisposition/diagnostic testing for myocardial infarction, thrombosis risk, arrhythmias
The utility of prognostic markers (e.g. CardioDx test)
Managing dose, efficacy and side effects of cardiovascular drugs using pharmacogenomics

Clopidogrel, Warfarin, Simvastatin

Chapter 7: Infectious disease

How is precision medicine being applied in infectious disease?

Managing dose, efficacy and side effects of ID drugs using pharmacogenomics

* Tracking outbreaks, pathogen discovery

* Future prospects: diagnostic sequencing

Chapter 8: Cancer

How is precision medicine being applied in cancer?

Diagnostic/predisposition testing for Hereditary cancers

HBOC, Lynch Syndrome, rare hereditary cancer syndromes

Managing dose, efficacy and side effects of cancer drugs using pharmacogenetics

Irinotecan, Belinostat, Azothioprine, Capecitaban, Tamoxifen, Oliparib

The genetic landscape of tumors
Prognostic markers
Targeted treatment and companion diagnostics
Tumor profiling and expanded treatment options
Future prospects: cfDNA for screening, diagnosing and monitoring cancer

Chapter 9: The Brain - Mental Health and Neurodegeneration

How is precision medicine being applied in mental health and neurodegenerative disease?

Predisposition/diagnostic testing for epilepsies, Alzheimer, Parkinson diseases
Managing dose, efficacy and side effects of antidepressant, antipsychotic, anti-seizure drugs using pharmacogenomics

Appendices. Conceptual framework for understanding genomic and precision medicine

Appendix 1: Genome variation

Describes the structure and organization of the human genome and the different types of variation, their consequences and distribution in different populations

DNA, RNA, Protein variation
Origin and types of genetic (DNA) variation (from big to small)
Consequences of genetic variation
Patterns of genetic variation across populations and ancestry

Appendix 2: Laboratory methods to detect genome variation

A roadmap of different testing methods that a practitioner may come across, what they can measure, and what are their limitations. Includes sample test requisitions and reports with graphical interpretation.

DNA variation (aCGH, karyotyping, FISH,Targeted genotyping, SNP arrays, Sanger and next-gen sequencing -whole genome, whole exome, panel)
The unique mitochondrial genome
RNA variation (QrtPCR, Transcript arrays, next-gen sequencing)
Protein variation (IHC, mass spectrometry)
Epigenome variation (Bisulfite sequencing)
How to find a testing laboratory (general information, specifics discussed within each disease type)

Appendix 3: Genetic variation and disease

How is genetic variation related to disease?

Inheritance patterns
Penetrance, expressivity, environmental influences
Family history: why it still matters

Appendix 4: Evidence base

How do we know if a gene-trait association is valid or clinically useful?

* Evaluating the evidence

o Establishing the role of the gene in disease

* Clinical validity (PPV, NPV)

* Clinical utility (cost effectiveness, comparative effectiveness)

* Where to find evidence, information and practice guidelines

How do we determine pathogenicity of variants in a diagnostic setting?

* Different types of evidence used in variant classification

* ACMG framework for variant classification

* Clinvar and other variant databases

Appendix 5: Regulation and reimbursement

How do regulation and reimbursement play a role in the delivery of precision medicine?

US FDA and genetic testing
Insurance coverage of genomic t
ests in the US

* Access to genetic testing

Appendix 6: Cross-cutting ethical issues

What key ethical issues to be aware of with genetic testing?

Secondary/incidental findings
Discrimination and GINA
Privacy and sharing
Testing minors
Population screening
Eugenics and disability rights
How to gather appropriate informed consent